PTPN12 and breast carcinoma: CD99CRIII3 dose-dependently suppressed the growth of MDA-MB-231 human breast cancer cells implanted in nude mice, while it failed to suppress the growth of shPTPN12-MDA-MB-231 cells implanted in nude mice, suggesting that PTPN12 serves as a key executor of the CD99 signaling pathway.